Stock Research: Dis-Chem Pharmacies

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Dis-Chem Pharmacies

JSE:DCP ZAE000227831
49
  • Value
    44
  • Growth
    75
  • Safety
    Safety
    17
  • Combined
    32
  • Sentiment
    58
  • 360° View
    360° View
    49
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Dis-Chem Pharmacies Limited is a South Africa-based company retailing and wholesaling affordable healthcare products and pharmaceuticals. It operates in the retail and wholesale industries. The company operates in South Africa. In the last fiscal year, the company had a market cap of $1,546 million, profits of $472 million, and revenue of $2,100 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 49 (better than 49% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dis-Chem Pharmacies are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Dis-Chem Pharmacies. The consolidated Growth Rank has a good rank of 75, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 75% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 58, which means that professional investors are more optimistic about the stock than for 58% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 17, which means that the share price of Dis-Chem Pharmacies is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 83% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 44, which means that the company has a financing structure that is riskier than those of 56% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
JSE All Shares
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
17 15 23 23
Growth
75 97 57 53
Safety
Safety
44 47 56 38
Sentiment
58 70 27 43
360° View
360° View
49 75 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
69 70 54 17
Opinions Change
50 50 29 50
Pro Holdings
n/a 83 31 65
Market Pulse
31 41 40 52
Sentiment
58 70 27 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
17 15 23 23
Growth
75 97 57 53
Safety Safety
44 47 56 38
Combined
32 57 36 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 25 31 33
Price vs. Earnings (P/E)
44 49 50 43
Price vs. Book (P/B)
15 15 18 13
Dividend Yield
32 32 39 33
Value
17 15 23 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
86 86 70 56
Profit Growth
46 74 44 50
Capital Growth
70 96 41 17
Stock Returns
49 69 55 85
Growth
75 97 57 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
34 31 36 28
Refinancing
49 52 53 51
Liquidity
56 57 60 47
Safety Safety
44 47 56 38

Similar Stocks

Discover high‑ranked alternatives to Dis-Chem Pharmacies and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Suzano

BOVESPA:SUZB3
Country: Brazil
Industry: Paper Products
Size: X-Large
Full Stock Analysis

Motus Holdings

JSE:MTH
Country: South Africa
Industry: Automotive Retail
Size: Medium
Full Stock Analysis

Exxaro

JSE:EXX
Country: South Africa
Industry: Coal & Consumable Fuels
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.